Drug Testing and Analysis

Papers
(The H4-Index of Drug Testing and Analysis is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Dr. Alan Malcolm Duffield85
Electrophoretic detection of black market myostatin propeptide57
Cover Picture55
35
Issue Information35
Assay validation for vilanterol and its metabolites in human urine with application for doping control analysis31
Issue Information27
27
Hair EtG Testing in Combination With Measurements of PEth and EtG in Blood to Improve the Assessment of Alcohol Consumption27
UHPLC–MS/MS method for the quantification of ultra‐traces of irinotecan and its metabolites in red blood cells and plasma to detect caregivers' contamination27
Origin and Interpretation of Low Methamphetamine Levels Found in Amphetamine‐Positive Urine Samples: Support for Methylation of Amphetamine as a Minor Metabolic Pathway27
Identification of Hexahydrocannabiphorol Metabolites in Human Urine26
Simulation of the Metabolism of New Psychoactive Substances Using Electrochemistry‐Mass Spectrometry: Introducing an Innovative Software Tool for Rapid Data Evaluation26
Biosynthesis and Identification of Clenbuterol Metabolites in Urine and In Vitro Microsome Incubation Samples Using UHPLC‐Q‐Exactive Orbitrap Mass Spectrometry: A Comparison Between Human and Bovine M26
Presence of β2‐agonist growth promoters in human urine samples: GC‐MS/MS evaluation of the excretion profiles of ractopamine administered in microdoses23
Carfentanil structural analogs found in street drugs by paper spray mass spectrometry and their characterization by high‐resolution mass spectrometry22
Cost Minimized Immunoaffinity Purification of EPO and Its Analogs in Doping Control—A Step‐by‐Step Protocol for Human Urine and Blood22
False‐Positive EtG Immunoassay Screening After Exposure to Aliphatic Alcohols. LC‐HRAM‐Orbitrap‐MS Detection of C1–C6 EtG Homologs in Urine, Chest, and Pubic Hair Samples22
Does a hair test allow discriminating a tail end of a doping regimen from a contamination in case of challenging an anti‐doping rule violation? II. Case report involving chlortalidone22
Emerging Human Medications in Racing Animals: Analytical and Regulatory Challenges21
In vitro metabolite identification of acetylbenzylfentanyl, benzoylbenzylfentanyl, 3‐fluoro‐methoxyacetylfentanyl, and 3‐phenylpropanoylfentanyl using LC‐QTOF‐HRMS together with synthesized references20
0.088749885559082